2018
DOI: 10.12688/f1000research.14133.2
|View full text |Cite
|
Sign up to set email alerts
|

Role of extracellular matrix in breast cancer development: a brief update

Abstract: Evidence is increasing on the crucial role of the extracellular matrix (ECM) in breast cancer progression, invasion and metastasis with almost all mortality cases owing to metastasis. The epithelial-mesenchymal transition is the first signal of metastasis involving different transcription factors such as Snail, TWIST, and ZEB1. ECM remodeling is a major event promoting cancer invasion and metastasis; where matrix metalloproteinases (MMPs) such as MMP-2, -9, -11, and -14 play vital roles degrading the matrix pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
48
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(51 citation statements)
references
References 79 publications
2
48
1
Order By: Relevance
“…The interaction of breast epithelium and stroma promotes normal breast structure and function [1]. However, adipose tissue surrounding breast tumors is no longer recognized as a passive structural element, but as a key component contributing to breast cancer progression [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…The interaction of breast epithelium and stroma promotes normal breast structure and function [1]. However, adipose tissue surrounding breast tumors is no longer recognized as a passive structural element, but as a key component contributing to breast cancer progression [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…In the latter case, C1 annotation was based on different gene‐expression signatures (GES), GOEA, and AR and FOXA1 IHC. Proteomics data were more effective than transcriptomics data to underscore invasion and migration in C2 through identification of numerous ECM proteins . ECM dynamics is deregulated in breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, a high activity of MMP-2 and MMP-9 has been observed in the serum and tissues of patients with breast cancer compared to healthy individuals [33,34]. Several signaling pathways, such as WNT, PI3K/AKT, MAPK, JNK, focal adhesion kinase (FAK) and Src, are activated during the remodeling of the ECM [35]. Among these kinases, the secretion and activation of MMP-2 and MMP-9 in breast cancer cell lines is dependent on the cytosolic tyrosine kinases Src [36,37,38,39], and FAK [40,41].…”
Section: Introductionmentioning
confidence: 99%